| Jane E Reid, MD | |
|
855 N Westhaven Dr, Oshkosh, WI 54904-7668 | |
| (920) 303-8700 | |
| Not Available |
| Full Name | Jane E Reid |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 30 Years |
| Location | 855 N Westhaven Dr, Oshkosh, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528042793 | NPI | - | NPPES |
| VANROJAN | Other | WI | MERCYCARE INSURANCE |
| 1528042793 | Other | WI | VANROJAN |
| 32216800 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 37068-20 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Divine Savior Healthcare | Portage, WI | Hospital |
| Naples Community Hospital | Naples, FL | Hospital |
| Ascension St Michaels Hospital | Stevens point, WI | Hospital |
| Aurora Medical Ctr Oshkosh | Oshkosh, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aspirus Stevens Point Hospital And Clinics, Inc. | 1850358938 | 115 |
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
| Divine Savior Healthcare Inc | 5799684007 | 77 |
| Rae Holdings Ltd | 6002141900 | 2 |
| Southwest Florida Emergency Management Llc | 0648314393 | 40 |
News Archive
Researchers in the U.S. say that just 10 minutes of exercise a day can help even the most inactive overweight women.
Radiation therapists and physicians know that education can reduce anxiety before radiation treatment but lack a standardized tool. In an effort to solve this problem, a multidisciplinary team from Jefferson College of Health Professions and Sidney Kimmel Cancer Center at Thomas Jefferson University conducted a pilot study to see if a virtual environment education program could reduce some of the anxiety their patients face.
Several presentations by deCODE genetics scientists and independent researchers at the American Heart Association Scientific Sessions 2008 being held at the New Orleans Convention Center from November 8 to12 are expected to expand upon the clinical utility of evaluating individual risk of heart attack, or atrial fibrillation and stroke, respectively, by measuring the genetic markers that are the basis of the deCODE MI and deCODE AF tests.
Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.
› Verified 3 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
Researchers in the U.S. say that just 10 minutes of exercise a day can help even the most inactive overweight women.
Radiation therapists and physicians know that education can reduce anxiety before radiation treatment but lack a standardized tool. In an effort to solve this problem, a multidisciplinary team from Jefferson College of Health Professions and Sidney Kimmel Cancer Center at Thomas Jefferson University conducted a pilot study to see if a virtual environment education program could reduce some of the anxiety their patients face.
Several presentations by deCODE genetics scientists and independent researchers at the American Heart Association Scientific Sessions 2008 being held at the New Orleans Convention Center from November 8 to12 are expected to expand upon the clinical utility of evaluating individual risk of heart attack, or atrial fibrillation and stroke, respectively, by measuring the genetic markers that are the basis of the deCODE MI and deCODE AF tests.
Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.
› Verified 3 days ago
| Entity Name | The Medical College Of Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699720086 PECOS PAC ID: 2668384371 Enrollment ID: O20031120000259 |
News Archive
Researchers in the U.S. say that just 10 minutes of exercise a day can help even the most inactive overweight women.
Radiation therapists and physicians know that education can reduce anxiety before radiation treatment but lack a standardized tool. In an effort to solve this problem, a multidisciplinary team from Jefferson College of Health Professions and Sidney Kimmel Cancer Center at Thomas Jefferson University conducted a pilot study to see if a virtual environment education program could reduce some of the anxiety their patients face.
Several presentations by deCODE genetics scientists and independent researchers at the American Heart Association Scientific Sessions 2008 being held at the New Orleans Convention Center from November 8 to12 are expected to expand upon the clinical utility of evaluating individual risk of heart attack, or atrial fibrillation and stroke, respectively, by measuring the genetic markers that are the basis of the deCODE MI and deCODE AF tests.
Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.
› Verified 3 days ago
| Entity Name | Memorial Hospital Of Boscobel |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760459846 PECOS PAC ID: 8325957673 Enrollment ID: O20040115000725 |
News Archive
Researchers in the U.S. say that just 10 minutes of exercise a day can help even the most inactive overweight women.
Radiation therapists and physicians know that education can reduce anxiety before radiation treatment but lack a standardized tool. In an effort to solve this problem, a multidisciplinary team from Jefferson College of Health Professions and Sidney Kimmel Cancer Center at Thomas Jefferson University conducted a pilot study to see if a virtual environment education program could reduce some of the anxiety their patients face.
Several presentations by deCODE genetics scientists and independent researchers at the American Heart Association Scientific Sessions 2008 being held at the New Orleans Convention Center from November 8 to12 are expected to expand upon the clinical utility of evaluating individual risk of heart attack, or atrial fibrillation and stroke, respectively, by measuring the genetic markers that are the basis of the deCODE MI and deCODE AF tests.
Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.
› Verified 3 days ago
| Entity Name | Divine Savior Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124083894 PECOS PAC ID: 5799684007 Enrollment ID: O20040225000909 |
News Archive
Researchers in the U.S. say that just 10 minutes of exercise a day can help even the most inactive overweight women.
Radiation therapists and physicians know that education can reduce anxiety before radiation treatment but lack a standardized tool. In an effort to solve this problem, a multidisciplinary team from Jefferson College of Health Professions and Sidney Kimmel Cancer Center at Thomas Jefferson University conducted a pilot study to see if a virtual environment education program could reduce some of the anxiety their patients face.
Several presentations by deCODE genetics scientists and independent researchers at the American Heart Association Scientific Sessions 2008 being held at the New Orleans Convention Center from November 8 to12 are expected to expand upon the clinical utility of evaluating individual risk of heart attack, or atrial fibrillation and stroke, respectively, by measuring the genetic markers that are the basis of the deCODE MI and deCODE AF tests.
Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.
› Verified 3 days ago
| Entity Name | Aspirus Stevens Point Hospital & Clinics, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538112230 PECOS PAC ID: 1850358938 Enrollment ID: O20041210000558 |
News Archive
Researchers in the U.S. say that just 10 minutes of exercise a day can help even the most inactive overweight women.
Radiation therapists and physicians know that education can reduce anxiety before radiation treatment but lack a standardized tool. In an effort to solve this problem, a multidisciplinary team from Jefferson College of Health Professions and Sidney Kimmel Cancer Center at Thomas Jefferson University conducted a pilot study to see if a virtual environment education program could reduce some of the anxiety their patients face.
Several presentations by deCODE genetics scientists and independent researchers at the American Heart Association Scientific Sessions 2008 being held at the New Orleans Convention Center from November 8 to12 are expected to expand upon the clinical utility of evaluating individual risk of heart attack, or atrial fibrillation and stroke, respectively, by measuring the genetic markers that are the basis of the deCODE MI and deCODE AF tests.
Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.
› Verified 3 days ago
| Entity Name | American Current Care Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477730356 PECOS PAC ID: 9739260019 Enrollment ID: O20091113000542 |
News Archive
Researchers in the U.S. say that just 10 minutes of exercise a day can help even the most inactive overweight women.
Radiation therapists and physicians know that education can reduce anxiety before radiation treatment but lack a standardized tool. In an effort to solve this problem, a multidisciplinary team from Jefferson College of Health Professions and Sidney Kimmel Cancer Center at Thomas Jefferson University conducted a pilot study to see if a virtual environment education program could reduce some of the anxiety their patients face.
Several presentations by deCODE genetics scientists and independent researchers at the American Heart Association Scientific Sessions 2008 being held at the New Orleans Convention Center from November 8 to12 are expected to expand upon the clinical utility of evaluating individual risk of heart attack, or atrial fibrillation and stroke, respectively, by measuring the genetic markers that are the basis of the deCODE MI and deCODE AF tests.
Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.
› Verified 3 days ago
| Entity Name | Froedtert &the Medical College Of Wisconsin Community Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568787448 PECOS PAC ID: 3678760063 Enrollment ID: O20101210000699 |
News Archive
Researchers in the U.S. say that just 10 minutes of exercise a day can help even the most inactive overweight women.
Radiation therapists and physicians know that education can reduce anxiety before radiation treatment but lack a standardized tool. In an effort to solve this problem, a multidisciplinary team from Jefferson College of Health Professions and Sidney Kimmel Cancer Center at Thomas Jefferson University conducted a pilot study to see if a virtual environment education program could reduce some of the anxiety their patients face.
Several presentations by deCODE genetics scientists and independent researchers at the American Heart Association Scientific Sessions 2008 being held at the New Orleans Convention Center from November 8 to12 are expected to expand upon the clinical utility of evaluating individual risk of heart attack, or atrial fibrillation and stroke, respectively, by measuring the genetic markers that are the basis of the deCODE MI and deCODE AF tests.
Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.
› Verified 3 days ago
| Entity Name | Rae Holdings Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922574417 PECOS PAC ID: 6002141900 Enrollment ID: O20190917002939 |
News Archive
Researchers in the U.S. say that just 10 minutes of exercise a day can help even the most inactive overweight women.
Radiation therapists and physicians know that education can reduce anxiety before radiation treatment but lack a standardized tool. In an effort to solve this problem, a multidisciplinary team from Jefferson College of Health Professions and Sidney Kimmel Cancer Center at Thomas Jefferson University conducted a pilot study to see if a virtual environment education program could reduce some of the anxiety their patients face.
Several presentations by deCODE genetics scientists and independent researchers at the American Heart Association Scientific Sessions 2008 being held at the New Orleans Convention Center from November 8 to12 are expected to expand upon the clinical utility of evaluating individual risk of heart attack, or atrial fibrillation and stroke, respectively, by measuring the genetic markers that are the basis of the deCODE MI and deCODE AF tests.
Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jane E Reid, MD Po Box 735044, Chicago, IL 60673-5044 Ph: (800) 326-2250 | Jane E Reid, MD 855 N Westhaven Dr, Oshkosh, WI 54904-7668 Ph: (920) 303-8700 |
News Archive
Researchers in the U.S. say that just 10 minutes of exercise a day can help even the most inactive overweight women.
Radiation therapists and physicians know that education can reduce anxiety before radiation treatment but lack a standardized tool. In an effort to solve this problem, a multidisciplinary team from Jefferson College of Health Professions and Sidney Kimmel Cancer Center at Thomas Jefferson University conducted a pilot study to see if a virtual environment education program could reduce some of the anxiety their patients face.
Several presentations by deCODE genetics scientists and independent researchers at the American Heart Association Scientific Sessions 2008 being held at the New Orleans Convention Center from November 8 to12 are expected to expand upon the clinical utility of evaluating individual risk of heart attack, or atrial fibrillation and stroke, respectively, by measuring the genetic markers that are the basis of the deCODE MI and deCODE AF tests.
Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.
› Verified 3 days ago
John M Rosebush Jr., MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 920-456-7400 Fax: 920-456-7421 | |
Kevin L Polglaze, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 920-490-9046 | |
Trevor C Fenrich, EMT-B Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 621 Evans St, Oshkosh, WI 54901 Phone: 920-233-0888 | |
Jayzon P Martonito, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 920-303-8700 | |
Daniel Gale, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 920-456-7400 Fax: 920-456-7421 | |
Benjamin Genesis M Bautista Ii, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 855 N Westhaven Dr, Oshkosh, WI 54904 Phone: 920-456-7400 |